Fidelity Investments today will announce its entry into the stock transfer agent market, with an all-digital solution that it's been quietly testing for the past year.

Why it matters: Stock transfer is vital to capital markets transactions, including both IPOs and M&A, but it's also dominated by an oligopoly that has a habit of driving CFOs to slam their fists into walls.

• When BuzzFeed went public via SPAC in late 2021 and ex-employees were unable to sell their shares because of stock transfer troubles, one venture capitalist told me he'd back "any entrepreneur on the planet who can solve this problem at scale."
• He certainly wasn't thinking of Fidelity, one of the world's largest asset managers, as the hero he needed. But this is where we're at.

The big picture: Fidelity's stock transfer effort is the brainchild of Schuyler Laird, a managing director in the firm's innovation incubator unit, Fidelity Labs.

• "I'd previously been at a tech startup acquired by a publicly traded company, and I saw a lot of what you covered with BuzzFeed," he explains. "A lot of Fidelity clients had seen the problems too and asked if Fidelity could do that work for them, so it was a bit of serendipity of me joining at the right time and having the right focus."
• Laird adds that while existing stock transfer agents aren't exactly analog, they rely a lot of email communication and often treat intraday requests as overnight requests. By authenticating digitally, he argues that Fidelity's effort will "do things at the speed of the internet, not at the speed of postage."

Zoom in: Fidelity only will work with publicly traded companies, or companies going public, leaving white space for existing players like SRS Acquiom (which focuses on private company mergers).

• It will operate independently of Fidelity Asset Management, to prevent conflicts of interest. Including among the firm's plethora of unicorn holdings.

The bottom line: Stock transfer will never be exciting. But it might be getting a little less boring.

Johnson & Johnson (NYSE: JNJ) agreed to acquire CNS biotech Intra-Cellular Therapies (Nasdaq: ITCI) for $14.6 billion in cash, or $132 per share.

Why it's the BFD: This would be the largest biotech merger since 2023, nearly tripling the size of last year's record-holder (Vertex/Alpine Immune).

• It also kicks off the JPM Healthcare Conference, which is where future mergers often get hatched.

By the numbers: Intra-Cellular shares jumped nearly 15% on Friday, on an announcement that it had settled a patent dispute with Sandoz over the bipolar drug Caplyta.

• J&J is paying around a 60% premium to Thursday's closing price and a 39% premium to Friday's closing price.

The bottom line: "Intra-Cellular develops new treatments for mental health disorders and neurological conditions and is currently working on a drug for major depressive disorder that's in late-stage trials." — Bloomberg

🚑 Truveta, a Bellevue, Wash., health data platform that's building a genetics database, raised $320m at more than a $1b valuation from Regeneron, Illumina and 17 U.S. health systems. axios.link/4jbTIKw

🚑 Tune Therapeutics, a Durham, N.C., epigenome editing company, raised $175m in Series B funding from NEA, Yosemite, Regeneron Ventures and Hevolution Foundation. axios.link/4adwKhW

🚑 Cera, a U.K. in-home healthcare startup, raised $150m in debt and equity funding (it didn't provide the split) co-led by BDT & MSD Partners and Schroders Capital. axios.link/4gPHllz

🚑 Qventus, an SF-based provider of hospital management automation software, raised $85m in Series D equity funding (plus $20m in debt). KKR led, and was joined by insider Bessemer Venture Partners. axios.link/4amFi6f

• Float Financial, a Toronto-based expense management and corporate card startup, raised C$70m in Series B funding. Goldman Sachs Alternatives led, and was joined by OMERS Ventures, FJ Labs, Teralys, and insider Garage Capital. axios.link/4heiGXI

• Overhaul, an Austin provider of supply chain risk management solutions, raised $55m. Springcoast Partners led, and was joined by insiders Edison Partners and Americo. axios.link/40gNFM7

🚑 Clear Labs, a San Carlos, Calif., sequencing platform for turnkey diagnostics, raised a $30m in Series D funding, per Axios Pro. Backers include Counterpoint Global, Felicis, GV, HBM Genomics, Khosla Ventures, Menlo Ventures, Nimble Ventures, Redmile Group, T. Rowe Price, and Wing VC. axios.link/4gQw2d7

🚑 Labviva, a Boston-based procurement platform for life sciences, raised $25m in Series B funding. 53 Stations led, and was joined by insiders Biospring Partners, B Capital Group, and Glasswing Ventures. axios.link/4fSADdn

• Nsave, a Swiss savings app for people living in unstable economies, raised $18m in Series A funding. TQ Ventures led, and was joined by Sequoia Capital, YC, ACE Ventures, and Proton Foundation. axios.link/3PSodb7

🚑 First Ascent Biomedical, a Miami-based oncology drug prediction platform, raised $6m from Vidal Duart Enterprises and Techstars, per Axios Pro. axios.link/40c0uHC

• Intelex Vision, a British provider of video analytics for real-time surveillance, raised £5.6m in Series A funding from Acurio Ventures, Adara Ventures, and Inveready. intelexvision.com

• Oh, a British developer of decentralized AI tools, raised $4.5m in seed funding from Tangent, Big Brain Holdings, Kosmos Ventures, Tagus Capital, and Bodhi Ventures. axios.link/4h9G0Ga

• Act III Holdings invested in Honest Greens Barcelona, a fast-casual restaurant chain with 30 locations in Spain and Portugal. axios.link/4hcxYw2

• ADIA and GIC acquired minority stakes in Pye-Barker, an Alpharetta, Ga., fire protection company whose existing backers include Altas Partners and Leonard Green & Partners. pyebarkerfs.com

• Bain Capital upped its takeover offer for Australian wealth manager Insignia Financial to US$1.8b, matching a bid from CC Capital Partners. axios.link/4abuXdj

• Consortium Brand Partners acquired Jonathan Adler, a home décor and furniture company. jonathanadler.com

• GTCR invested in Winged Keel, a New York-based life insurance brokerage focused on inter-generational wealth and estate planning strategies. wingedkeel.com

• Infranity acquired a majority stake in Nordic Re-Finance, a Swedish locomotives lessor. axios.link/4fXQR59

🚑 New Mountain Capital agreed to acquire Machinify, a Palo Alto, Calif., provider of health-care payments software. machinify.com

🚑 PAG acquired a majority stake in Pravesha Industries, an Indian packaging firm focused on pharma. axios.link/3DVgVjZ

🚑 WindRose Health Investors invested in Civie, a provider of AI-powered radiology solutions. civie.com

Flowco, a PE-backed provider of oil and gas well equipment and services, is planning the week's only major U.S. IPO. axios.link/4abIoKn

🚑 Metsera, a New York-based developer of medicines for obesity and metabolic diseases, filed for an IPO. The pre-revenue company plans to list on the Nasdaq (MSTR) and has raised $565m from Arch Venture Partners (28.1% pre-IPO stake), Population Health Partners (14.6%), Fidelity (8.1%), GV, (5.7%), Newpath Partners (5.6%), Mubadala (5.2%), SoftBank (5.5%), Wellington, Venrock, Janus Henderson, T. Rowe Price, Viking Global Investors, Deep Track Capital, RA Capital Management, Alpha Wave Ventures, and SymBiosis. axios.link/3DSHFBB

• Verisure, a Swiss fire and security alarm maker owned by Hellman & Friedman, is prepping an IPO that could value the company at more than €20b, per Sky News. It most likely would list in London or Amsterdam. axios.link/40ytBFh

🌎 CH4 Natural Solutions Acquisition, a SPAC targeting companies that could benefit from methane mitigation, filed for a $250m IPO. It was formed by Impact Ag, Riverstone's David Leuschen, and Overview Capital's Lauren Singer. axios.link/4huPlJ1

• Live Oak Acquisition V, a SPAC formed by Live Oak Merchant Partners, filed for a $200m IPO. axios.link/4jeqquH

• Origin Investment I, a SPAC targeting midmarket growth businesses in Asia, filed for a $60m IPO. axios.link/3WfL0kA

• Blackstone is weighing a sale of Liftoff, a Redwood City, Calif.-based mobile marketing provider of that could fetch more than $4b (including debt), per Reuters. axios.link/3PBKLwg

🚑 GSK (LSE: GSK) agreed to buy IDRx, a Plymouth, Mass.-based developer of precision combination therapies for cancer, for up to $1.15b (including $1b upfront). IDRx had raised over $240m from firms like a16z, Casdin Capital, Blackstone, RA Capital Management, Merck, Nextech Invest, and Forge Life Science Partners. axios.link/426A3pe

• KKR is exploring options for U.K. waste management company Viridor, which could fetch up to £7b (including debt). axios.link/4hbmg58

• Acciaierie d'Italia (fka Ilva), Italy's largest steelmaker, has received 10 takeover offers. axios.link/4japrvz

🚑 Biogen (Nasdaq: BIIB) offered to buy 89.8% it doesn't already hold in Sage Therapeutics (Nasdaq: SAGE) at $7.72 per share (30% premium to Friday's close). axios.link/40qyG3n

⚡ Chow Tai Fook Enterprises is weighing a stake sale in Australian electricity provider Alinta Energy, per Bloomberg. axios.link/4gOzF3i

• Clearwater Analytics (NYSE: CWAN) agreed to buy Enfusion (NYSE: ENFN), a Chicago-based provider of investment management and hedge fund SaaS, for $1.5b, per $11.25 per share. axios.link/40tNOwN

• Stroeer, a listed German advertising group, says it's received indicative offers from private equity for its out-of-home and digital businesses. axios.link/4heZnhb

• T-Mobile (Nasdaq: TMUS) agreed to acquire Vistar Media, a provider of tech solutions for digital-out-of-home(advertising, for $600m. vistarmedia.com

🚑 Andreessen Horowitz and Eli Lilly have launched a $500m fund focused on new medicines, which is designed to act as a "complement" to traditional VC. axios.link/4amtAbN

🚑 Hildred Capital Management raised $800m for its third midmarket health-care fund. hildred.com

• Medalist Partners is targeting $750m for its fourth private credit fund, per the WSJ. axios.link/4gPIV6Z

• Root Ventures is raising up to $250m for its fourth fund, per an SEC filing.

• Ares Management named Kevin Alexander as co-head of alternative credit, alongside Keith Ashton and Joel Holsinger. axios.link/4ajIZtl

• Zeeza Cole joined Avid Ventures as a partner. She previously was with Bain Capital Partners. Avid also promoted Tali Miller to partner. avidventures.com

• Jonas Nilsson joined Berkshire Partners as a managing director and head of investor relations. He previously was with Cinven. berkshirepartners.com

🚑 John Kerins joined Piper Sandler as a managing director of health-care investment banking. He previously was with Cain Brothers & Co. axios.link/4fU0FNy

• O2 Investment Partners promoted Michael Cotant, Derek Wardlaw, and Andrew Faubel to partners, and Shyam Shah, Sam Wegenke, Mark Heneman, and William Laffrey to vice presidents. o2investment.com

Bill Ackman today offered to buy the 62% stake he doesn't already hold in property firm Howard Hughes Holdings (NYSE: HHH) for $85 per share, and then convert HHH into a publicly-traded platform for buying other companies.

• The proposal involves Ackman's Pershing Square Capital Management forming a new subsidiary that would buy HHH — with a pledge that the new vehicle would hold HHH "forever."
• Put another way, this is Ackman's way of trying to create Buffett-style permanent capital, albeit with commercial real estate base instead of an insurance base.